Archivos mensuales: septiembre 2022

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, et al

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, et al 147. Brentuximab vedotin or physician's selection within the CD30-self-confident cutaneous T-telephone lymphoma (ALCANZA): a worldwide, open-label, randomised, stage step three, multicentre demonstration. Lancet (2017) –66. doi: /S0140-6seven36(17)31266-seven 148. DeFilipp Z, Li S, Kempner Me personally, Brown J, Del Rio C, Valles…
Más